Element Capital Management LLC Makes New $5.03 Million Investment in HCA Healthcare, Inc. $HCA

Posted by Stanley Muller on Aug 26th, 2026

Element Capital Management LLC bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) in the 2nd quarter, HoldingsChannel.com reports. The firm bought 12,900 shares of the company’s stock, valued at approximately $5,030,000. HCA Healthcare makes up about 0.2% of Element Capital Management LLC’s portfolio, making the stock its 29th largest holding.

Other large investors have also recently added to or reduced their stakes in the company. Sumitomo Life Insurance Co. raised its stake in shares of HCA Healthcare by 1.0% in the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock valued at $946,000 after purchasing an additional 20 shares in the last quarter. MJP Associates Inc. ADV increased its holdings in HCA Healthcare by 2.9% in the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after buying an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC grew its position in shares of HCA Healthcare by 7.5% in the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after acquiring an additional 21 shares in the last quarter. Anchyra Partners LLC raised its position in shares of HCA Healthcare by 3.7% during the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock valued at $278,000 after acquiring an additional 21 shares in the last quarter. Finally, Plato Investment Management Ltd increased its stake in HCA Healthcare by 0.6% during the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after purchasing an additional 22 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $428.90 on Wednesday. HCA Healthcare, Inc. has a 1 year low of $353.99 and a 1 year high of $556.52. The firm has a market capitalization of $92.86 billion, a PE ratio of 14.36, a price-to-earnings-growth ratio of 1.49 and a beta of 1.10. The stock has a fifty day moving average of $398.59 and a two-hundred day moving average of $442.83.

HCA Healthcare (NYSE:HCA – Get Free Report) last issued its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The company’s revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the business earned $6.84 earnings per share. Equities research analysts predict that HCA Healthcare, Inc. will post 29.42 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.

Analysts Set New Price Targets

HCA has been the subject of several research reports. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $435.00 price target on shares of HCA Healthcare in a report on Monday, July 27th. Robert W. Baird decreased their target price on HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating for the company in a research note on Monday, July 27th. Argus dropped their price target on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. Cantor Fitzgerald lowered their price objective on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a research note on Tuesday, July 7th. Finally, KeyCorp cut their target price on HCA Healthcare from $475.00 to $435.00 and set an “overweight” rating on the stock in a research note on Monday, July 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $462.64.

Get Our Latest Stock Report on HCA Healthcare

HCA Healthcare Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.